Harry Suryapranata

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 638 citations · Full text

Medicine, Cardiology, Surgery +14

Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries

Patrick W. Serruys, Håkan Emanuelsson, Wim van der Giessen et al. · Circulation · 1996 · 404 citations

Medicine, Cardiology, Pharmacotherapy +17

Randomized Comparison of Coronary Stenting With Balloon Angioplasty in Selected Patients With Acute Myocardial Infarction

Harry Suryapranata, Arnoud W.J. van ’t Hof, Jan C.A. Hoorntje et al. · Circulation · 1998 · 349 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Folate Therapy and In-Stent Restenosis after Coronary Stenting

Helmut W. Lange, Harry Suryapranata, Giuseppe De Luca et al. · New England Journal of Medicine · 2004 · 337 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16